Alzheimer’s disease (AD) is the most common neurodegenerative disease, and is characterized by the abnormal processing of the amyloid precursor protein (APP) through the amyloidogenic pathway, and the hyperphosphorylation of TAU protein. This evidence concerns the gene APP and neurodegenerative disease.